Company news
Creo Medical Group PLC news in 2023
Creo Medical Group PLC's news releases, calls and decks from 2023, newest first.
First use of Speedboat® UltraSlim in the USA
December 15, 2023
First European Speedboat® UltraSlim procedure
December 13, 2023
Capital Markets Day
November 7, 2023
Speedboat® UltraSlim: US FDA Clearance
November 1, 2023
SB UltraSlim: EU launch accelerated by 18 months
October 25, 2023
Change of Nominated Adviser and Joint Broker
October 16, 2023
Investor Presentation
October 12, 2023
Half-year Report
September 12, 2023
Royal Oldham SSD service update
August 16, 2023
Half Year Trading Update
August 3, 2023
Issue of Equity and TVR
July 6, 2023
AGM Statement & Directorate Succession Planning
June 27, 2023
First upper GI Speedboat procedure in Europe
June 26, 2023
Appointment of Marco Scarci
June 22, 2023
Speedboat Inject upper GI clearance in Europe
June 19, 2023
Speedboat™ Inject selected by NICE for assessment
June 1, 2023
Posting of Annual Report and Notice of AGM
May 26, 2023
First in-human milestone for MicroBlate™ Flex
May 23, 2023
Royal Oldham Hospital Agreement
May 17, 2023
Attendance at Digestive Disease Week
May 15, 2023
Albyn Medical earn out update
April 14, 2023
MicroBlateT Flex clinical study
March 31, 2023
Director/PDMR and PCA Share Dealings
March 13, 2023
Result of GM
March 8, 2023
Second Price Monitoring Extn
March 6, 2023
Price Monitoring Extension
February 17, 2023
Result of Placing and Subscription
February 16, 2023
Creo Medical (CREO): Progressing on all fronts
January 23, 2023
FY 2022 Trading Update
January 11, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (March 2023)
Investor deck · 15 slides · March 2023